Foghorn Therapeutics Inc. Earnings Per Share (Basic)
Foghorn Therapeutics Inc. (FHTX) reported Earnings Per Share (Basic) of -$0.10 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- Foghorn Therapeutics Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.10.
- Foghorn Therapeutics Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.29.
- Foghorn Therapeutics Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.34.
- Foghorn Therapeutics Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.25.
- Foghorn Therapeutics Inc. earnings per share, basic for fiscal 2025 was -$1.18.
- Foghorn Therapeutics Inc. earnings per share, basic for fiscal 2024 was -$1.58.
- Foghorn Therapeutics Inc. earnings per share, basic for fiscal 2023 was -$2.34.
- Foghorn Therapeutics Inc. earnings per share, basic for fiscal 2022 was -$2.62.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.10 10-Q · filed 2026-08-06 | -$0.39 10-Q · filed 2026-08-06 | -$0.72 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.97 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2026-03-31 | -$0.29 10-Q · filed 2026-05-07 | -$0.63 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.88 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.17 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-12-31 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$0.59 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$0.88 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.18 10-K · filed 2026-03-11 |
| 2025-09-30 | -$0.25 10-Q · filed 2025-11-05 | -$0.54 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.84 10-Q · filed 2025-11-05 | -$1.15 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-06-30 | -$0.28 10-Q · filed 2026-08-06 | -$0.58 10-Q · filed 2026-08-06 | -$0.89 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.20 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-03-31 | -$0.30 10-Q · filed 2026-05-07 | -$0.61 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.92 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.34 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2024-12-31 | -$0.31 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$0.62 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$1.04 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$1.58 10-K · filed 2026-03-11 |
| 2024-09-30 | -$0.31 10-Q · filed 2025-11-05 | -$0.74 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$1.28 10-Q · filed 2025-11-05 | -$1.84 derived: net income ÷ weighted average shares · filed 2025-11-05 |
| 2024-06-30 | -$0.45 10-Q · filed 2025-08-05 | -$1.02 10-Q · filed 2025-08-05 | -$1.59 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$1.94 derived: net income ÷ weighted average shares · filed 2025-11-05 |
| 2024-03-31 | -$0.59 10-Q · filed 2025-05-14 | -$1.16 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$1.50 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$2.21 derived: net income ÷ weighted average shares · filed 2025-11-05 |
| 2023-12-31 | -$0.57 derived: net income ÷ weighted average shares · filed 2025-03-06 | -$0.91 derived: net income ÷ weighted average shares · filed 2025-03-06 | -$1.62 derived: net income ÷ weighted average shares · filed 2025-03-06 | -$2.34 10-K · filed 2025-03-06 |
| 2023-09-30 | -$0.34 10-Q · filed 2024-11-04 | -$1.05 derived: net income ÷ weighted average shares · filed 2024-11-04 | -$1.77 10-Q · filed 2024-11-04 | -$2.47 derived: net income ÷ weighted average shares · filed 2024-11-04 |
| 2023-06-30 | -$0.70 10-Q · filed 2024-08-08 | -$1.43 10-Q · filed 2024-08-08 | -$2.13 derived: net income ÷ weighted average shares · filed 2024-11-04 | -$2.74 derived: net income ÷ weighted average shares · filed 2024-11-04 |
| 2023-03-31 | -$0.73 10-Q · filed 2024-05-06 | -$1.42 derived: net income ÷ weighted average shares · filed 2024-11-04 | -$2.04 derived: net income ÷ weighted average shares · filed 2024-11-04 | -$2.70 derived: net income ÷ weighted average shares · filed 2024-11-04 |
| 2022-12-31 | -$0.69 derived: net income ÷ weighted average shares · filed 2024-03-07 | -$1.31 derived: net income ÷ weighted average shares · filed 2024-03-07 | -$1.97 derived: net income ÷ weighted average shares · filed 2024-03-07 | -$2.62 10-K · filed 2024-03-07 |
| 2022-09-30 | -$0.62 10-Q · filed 2023-11-02 | -$1.28 derived: net income ÷ weighted average shares · filed 2023-11-02 | -$1.93 10-Q · filed 2023-11-02 | -$2.68 derived: net income ÷ weighted average shares · filed 2023-11-02 |
| 2022-06-30 | -$0.66 10-Q · filed 2022-08-09 | -$1.31 10-Q · filed 2023-08-04 | -$2.07 derived: net income ÷ weighted average shares · filed 2023-11-02 | -$2.77 derived: net income ÷ weighted average shares · filed 2023-11-02 |
| 2022-03-31 | -$0.65 10-Q · filed 2023-05-08 | -$1.41 derived: net income ÷ weighted average shares · filed 2023-11-02 | -$2.12 derived: net income ÷ weighted average shares · filed 2023-11-02 | -$2.75 derived: net income ÷ weighted average shares · filed 2023-11-02 |
| 2021-12-31 | -$0.77 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$1.47 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$2.10 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$2.73 10-K · filed 2023-03-09 |
| 2021-09-30 | -$0.71 10-Q · filed 2022-11-08 | -$1.33 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$1.96 10-Q · filed 2022-11-08 | -$2.69 derived: net income ÷ weighted average shares · filed 2022-11-08 |
| 2021-06-30 | -$0.63 10-Q · filed 2022-08-09 | -$1.25 10-Q · filed 2022-08-09 | -$1.98 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$3.18 derived: net income ÷ weighted average shares · filed 2022-11-08 |
| 2021-03-31 | -$0.62 10-Q · filed 2022-05-09 | -$1.36 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$2.65 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$4.10 derived: net income ÷ weighted average shares · filed 2022-11-08 |
| 2020-12-31 | -$0.75 derived: net income ÷ weighted average shares · filed 2022-08-09 | -$2.33 derived: net income ÷ weighted average shares · filed 2022-08-09 | -$4.22 derived: net income ÷ weighted average shares · filed 2022-08-09 | -$6.23 10-K/A · filed 2022-08-09 |
| 2020-09-30 | -$3.12 10-Q · filed 2021-11-09 | -$6.03 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$8.76 10-Q · filed 2021-11-09 | |
| 2020-06-30 | -$2.90 10-Q · filed 2021-08-10 | -$5.61 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |